Related references
Note: Only part of the references are listed.Angiopoietin-1 Overexpression Modulates Vascular Endothelium to Facilitate Tumor Cell Dissemination and Metastasis Establishment
Tanja Holopainen et al.
CANCER RESEARCH (2009)
Antiangiogenic Gene Therapy With Soluble VEGFR-1,-2, and-3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice
Hanna Sallinen et al.
MOLECULAR THERAPY (2009)
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tuomas Tammela et al.
NATURE (2008)
Soluble receptor-mediated selective inhibition of VEGFR and PDGFRβ signaling during physiologic and tumor angiogenesis
Frank Kuhnert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular regulation of angiogenesis and lymphangiogenesis
Ralf H. Adams et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
A highly reproducible xenograft model for human ovarian carcinoma and application of MRI and ultrasound in longitudinal follow-up
Hanna Sallinen et al.
GYNECOLOGIC ONCOLOGY (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Lymphangiogenesis in development and human disease
K Alitalo et al.
NATURE (2005)
Regulation of the pathological vasculature of malignant astrocytomas by angiopoietin-1
G Zadeh et al.
NEOPLASIA (2005)
Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: Enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model
SP Raikwar et al.
MOLECULAR THERAPY (2005)
Angiopoietin-1 promotes lymphatic sprouting and hyperplasia
T Tammela et al.
BLOOD (2005)
Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo
N Jendreyko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2
P Saharinen et al.
JOURNAL OF CELL BIOLOGY (2005)
Periadventitial angiopoietin-1 gene transfer induces angiogenesis in rabbit carotid arteries
S Bhardwaj et al.
GENE THERAPY (2005)
Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer
K Hata et al.
GYNECOLOGIC ONCOLOGY (2004)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia -: Phase II results of the Kuopio Angiogenesis Trial (KAT)
M Hedman et al.
CIRCULATION (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1
NW Gale et al.
DEVELOPMENTAL CELL (2002)
Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer
K Hata et al.
ONCOLOGY (2002)
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
T Veikkola et al.
EMBO JOURNAL (2001)
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
T Mäkinen et al.
NATURE MEDICINE (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Vascular-specific growth factors and blood vessel formation
GD Yancopoulos et al.
NATURE (2000)
Share Paper
